85 related articles for article (PubMed ID: 18025806)
1. Synchronous endometrial carcinoma and a macroprolactinoma: exploring a causal relationship.
Sharma A; Sharma MS; De Padua M; Jha UP; Jha AN
Oncology; 2007; 72(1-2):139-42. PubMed ID: 18025806
[TBL] [Abstract][Full Text] [Related]
2. Endometrioid endometrial carcinoma indirectly caused by pituitary prolactinoma: a case report.
Nishino K; Niwa Y; Mizutani T; Shimizu K; Hayashi K; Chaya J; Kato N; Yamamuro O
Case Rep Oncol; 2013 Jan; 6(1):25-30. PubMed ID: 23467393
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacodynamic metoclopramide (cerucal) test in differential diagnosis of hypoprolactinemic hypogonadism syndrome in women].
Balabolkin MI; Gerasimov GA; Liubimov AV
Akush Ginekol (Mosk); 1990 Feb; (2):54-7. PubMed ID: 2339765
[TBL] [Abstract][Full Text] [Related]
4. Prolactinoma and systemic lupus erythematosus: do serum prolactin levels matter?
Li M; Keiser HD; Peeva E
Clin Rheumatol; 2006 Jul; 25(4):602-5. PubMed ID: 16404500
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
[TBL] [Abstract][Full Text] [Related]
6. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
[TBL] [Abstract][Full Text] [Related]
7. [The impact of prolactinoma in human reproduction].
Hurtado Amador R; Ayala AR; Hernández Marín I
Ginecol Obstet Mex; 2004 Jan; 72(1):3-9. PubMed ID: 15239558
[TBL] [Abstract][Full Text] [Related]
8. Pituitary prolactin-secreting tumor formation: recent developments.
Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
[TBL] [Abstract][Full Text] [Related]
9. Time Course of Resolution of Hyperprolactinemia After Transsphenoidal Surgery Among Patients Presenting with Pituitary Stalk Compression.
Zaidi HA; Cote DJ; Castlen JP; Burke WT; Liu YH; Smith TR; Laws ER
World Neurosurg; 2017 Jan; 97():2-7. PubMed ID: 27671881
[TBL] [Abstract][Full Text] [Related]
10. Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male.
Forloni F; Giovilli M; Pecis C; Bortolani E; Preziosi A; Barzaghi ME; Corti D; Beck-Peccoz P
J Endocrinol Invest; 2001 Jun; 24(6):454-9. PubMed ID: 11434671
[TBL] [Abstract][Full Text] [Related]
11. Prolactin-lowering effect of luteinizing hormone-releasing hormone agonist administration in prolactinoma patients.
Rubio MA; Cabranes JA; Schally AV; Charro AL
J Clin Endocrinol Metab; 1989 Aug; 69(2):444-7. PubMed ID: 2526819
[TBL] [Abstract][Full Text] [Related]
12. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
[TBL] [Abstract][Full Text] [Related]
13. [Diabetic ketoacidosis as the first manifestation of a mixed growth hormone and prolactin-secreting tumor].
Carrasco de la Fuente M; González-Albarrán O; Pérez López G; Cano Megías M
Endocrinol Nutr; 2010 Dec; 57(10):507-9. PubMed ID: 20705526
[No Abstract] [Full Text] [Related]
14. Chronic anemia as first clinical manifestation of a prolactin-secreting pituitary macroadenoma in a male patient.
Iglesias P; Díez JJ
Am J Med; 2011 Jun; 124(6):e3-4. PubMed ID: 21605718
[No Abstract] [Full Text] [Related]
15. Autoimmune hypothyroidism coexisting with a pituitary adenoma secreting thyroid-stimulating hormone, prolactin and alpha-subunit.
Idiculla JM; Beckett G; Statham PF; Ironside JW; Atkin SL; Patrick AW
Ann Clin Biochem; 2001 Sep; 38(Pt 5):566-71. PubMed ID: 11587139
[TBL] [Abstract][Full Text] [Related]
16. The role of serum PRL bioactivity evaluation in hyperprolactinaemic women with different menstrual disorders.
Kostrzak A; Warenik-Szymankiewicz A; Meczekalski B
Gynecol Endocrinol; 2009 Dec; 25(12):799-806. PubMed ID: 19905999
[TBL] [Abstract][Full Text] [Related]
17. A 22-year-old man with severe osteoporosis due to prolactinoma.
Dandinoğlu T; Akarsu S; Tekin L; Arbal S; Dinçer U
J Clin Rheumatol; 2013 Sep; 19(6):341-3. PubMed ID: 23965473
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic thrombocytopenic purpura associated with a prolactin-producing pituitary adenoma.
Kovacs K; Garvey MB
Am J Hematol; 2003 Sep; 74(1):55-9. PubMed ID: 12949891
[TBL] [Abstract][Full Text] [Related]
19. [Hypophyseal microprolactinoma as a cause of delayed puberty].
Heidemann PH; Stubbe P
Monatsschr Kinderheilkd; 1989 Nov; 137(11):743-6. PubMed ID: 2514354
[TBL] [Abstract][Full Text] [Related]
20. [Disappearance of the radiographic image of a macroprolactinoma after treatment with bromocriptine].
Forsbach G; Olivares F; Vázquez J; Güitrón A
Ginecol Obstet Mex; 1998 Apr; 66():170-2. PubMed ID: 9617019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
